Contrast Media

Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.

Sponsored Content | Videos | Contrast Media
VIDEO: Talking Trends with Bracco: Investing in the Future of Radiology

Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...

Time February 27, 2023
arrow
Contrast-enhanced ultrasound (CEUS) is more accurate and reliable than MRI for examining certain liver and kidney nodules
News | Ultrasound Imaging
Enhanced Ultrasound Superior to MRI for Diagnosing Certain Liver and Kidney Tumors, According to New Studies

February 24, 2023 — Contrast-enhanced ultrasound (CEUS) is more accurate and reliable than MRI for examining certain ...

Time February 24, 2023
arrow
First dosage administered at the Hospital of the University of Pennsylvania following FDA approval
News | Contrast Media
Guerbet Announces Commercial Launch and First Patient Dosing of Elucirem (Gadopiclenol) Injection

February 16, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced ...

Time February 16, 2023
arrow
Requiring half the gadolinium dosage compared to other macrocyclic gadolinium-based contrast agents (GBCAs) in approved indications in the U.S., gadopiclenol also has the highest relaxivity compared to approved GBCAs1-7
News | Contrast Media
First Nationwide Use of Bracco's VUEWAY (gadopiclenol) Solution for Injection for MRI

February 15, 2023 — Bracco Imaging, an innovative world leader delivering end-to-end products and solutions through a ...

Time February 15, 2023
arrow
News | Contrast Media
Efficacy and Safety of Gadopiclenol with Contrast-enhanced MRI of the Central Nervous System Published

February 6, 2023 — Bracco Imaging, an innovative world leader delivering end-to-end products and solutions through a ...

Time February 06, 2023
arrow
While the global COVID-19 pandemic took its toll on imaging diagnostics, the market for contrast agent injector systems is poised for significant growth for a range of reasons.
Feature | Contrast Media Injectors | By Christine Book
Contrast Media Injectors: Market Outlook and Opportunities

The vital, and growing role of contrast media, and the medical devices employed to inject the agent into the body ...

Time January 19, 2023
arrow
Bayer has announced the acquisition of Blackford Analysis Ltd., a global imaging AI platform and solutions provider.
News | Radiology Business
Bayer Announces Acquisition of Blackford Analysis to Advance AI in Radiology Imaging

January 18, 2023 — Addressing the growing demand for medical imaging and a shortage of radiologists, Bayer announced the ...

Time January 18, 2023
arrow
GE Healthcare will offer its own brand CT Motion injector, an innovative, multi-dose, syringeless technology developed and manufactured by ulrich medical, to a growing injector market in the U.S.
News | Computed Tomography (CT)
GE Healthcare and ulrich medical announce an Agreement to Offer a Branded Multi-dose Contrast Media Injector in the U.S.

December 12, 2022 — GE Healthcare announced an agreement with ulrich medical for a GE Healthcare branded contrast media ...

Time December 12, 2022
arrow
News | Contrast Media
Survey Reports Radiologist Input on Key Issues, MRI Contrast Agents

December 5, 2022 — Bracco Diagnostics Inc., a U.S. subsidiary of Bracco Imaging S.p.A., has announced results from a ...

Time December 05, 2022
arrow
Lab scale HTS magnet demonstrator
News | Magnetic Resonance Imaging (MRI)
Philips Signs Research Agreement to Explore New Magnet Technologies

December 5, 2022 — -Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has entered into a ...

Time December 05, 2022
arrow
News | RSNA
Study compares effect of food intake on manganese-based MRI contrast agent absorption

December 3, 2022 — Results from its Orviglance Food Effect study were presented by Ascelia Pharma, a biopharmaceutical ...

Time December 03, 2022
arrow
Guerbet LLC, the US affiliate of Guerbet, a global leader in medical imaging offering a comprehensive range of pharmaceutical products, medical devices, and digital and artificial intelligence (AI) solutions for diagnostic and interventional imaging, will present data on Elucirem (gadopiclenol) injection, Dotarem (gadoterate meglumine) injection and AI solutions at the 2022 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting. 
News | Contrast Media
Guerbet to Spotlight the Novel New Drug Elucirem (gadopiclenol) injection at RSNA22

November 26, 2022 — Guerbet LLC, the US affiliate of Guerbet, a global leader in medical imaging offering a ...

Time November 26, 2022
arrow
The new MEDRAD Centargo CT Injection System minimises your injector touch time by automating manual processes, helping you to focus on what matters most in every CT scan – the patient.
News | Computed Tomography (CT)
At RSNA, Bayer to Showcase Product Offerings and Announces Broadened AI Offering in Radiology

November 26, 2022 — As international leaders in the field of Imaging gather for the 2022 Radiological Society of North ...

Time November 26, 2022
arrow
Simulations by Rice University engineers have revealed details about the molecular interactions between gadolinium contrast agents used in MRI scans and their liquid environment. In this model, green gadolinium is surrounded by blue chelate ions, themselves surrounded by water (gray oxygen and red hydrogen atoms). Thiago Pinheiro dos Santos/Rice University
News | Magnetic Resonance Imaging (MRI)
Rice Refines Analysis of MRI Contrast Agents

November 21, 2022 — You can keep your best guesses. Engineers at Rice University’s George R. Brown School of Engineering ...

Time November 21, 2022
arrow
Top trends boosting the industry expansion through 2028
Feature | Contrast Media | By Shankar Khatkale
Imaging Contrast Agents Global Market Outlook

According to a recent study from market research firm Graphical Research, the global imaging agents market size is set ...

Time November 02, 2022
arrow
Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced the signing of a data-sharing agreement with Siemens Healthineers and the University Hospital of the Technical University of Munich (TUM) for anonymized 18F-rhPSMA-7.3 clinical data and images.
News | PET Imaging
Blue Earth Diagnostics Announces Data-sharing Agreement with Siemens Healthineers and the University Hospital of Technical University of Munich (TUM) for 18F-rhPSMA-7.3

October 19, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time October 19, 2022
arrow
Iodine prills – produced by SQM (Photo: Business Wire)
News | Contrast Media
GE Healthcare Announces Multi-Year Agreement with SQM to Secure Iodine Supply for Contrast Media

October 14, 2022 — GE Healthcare’s Pharmaceutical Diagnostics business has announced a long-term agreement with Chile ...

Time October 14, 2022
arrow
Bracco Diagnostics Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved Gadopiclenol Injection, a new, highly stable macrocyclic gadolinium-based contrast agent (GBCA), in partnership with Guerbet.. 
News | Contrast Media
Bracco and Guerbet Partner to Expand Access to Novel Imaging Agent

Editor’s note: On September 21, 2022, both Guerbet and Bracco Diagnostics released news detailing the FDA approval of a ...

Time September 22, 2022
arrow
Guerbet, a global medical imaging company, has announced that the U.S. Food and Drug Administration (FDA) after priority review, approved Elucirem (Gadopiclenol), a new macrocyclic GBCA for use in contrast-enhanced magnetic resonance imaging (MRI).
News | Contrast Media
Guerbet Announces FDA Approval of Elucirem (Gadopiclenol) for Use in Contrast-enhanced MRI

September 21, 2022 – Guerbet, a global medical imaging company, has announced that the U.S. Food and Drug Administration ...

Time September 21, 2022
arrow
Due to the siloed nature of healthcare networks today, approximately 40% of all medical imaging that patients receive is repeated, leading to higher healthcare costs and undue radiation exposure
Feature | Contrast Media | By Sheela Agarwal, MD, MBA
VIEWPOINT: How Connected Imaging Networks Can Help During the ICM Shortage

“Zero-COVID” policies have had a massive impact around the world. One consequence has been the recent global shortage in ...

Time September 14, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now